Bacteriophage can prevent encrustation and blockage of urinary catheters by Proteus mirabilis

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 3, 2016, Pages 1530-1536

  Nzakizwanayo, Jonathan ^a   Hanin, Aurélie ^b   Alves, Diana R ^a,c   McCutcheon, Benjamin ^a   Dedi, Cinzia ^a   Salvage, Jonathan ^a   Knox, Karen ^d   Stewart, Bruce ^d   Metcalfe, Anthony ^a,c   Clark, Jason ^e   Gilmore, Brendan F ^f   Gahan, Cormac G M ^b   Jenkins, A Toby A ^g   Jones, Brian V ^a,c  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c QUEEN VICTORIA HOSPITAL   (United Kingdom)

^d EAST SURREY HOSPITAL   (United Kingdom)

^e Novolytics Ltd   (United Kingdom)

^f QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^g University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIOPHAGE; BACTERIUM ISOLATE; BIOFILM; BLADDER CATHETERIZATION; CLINICAL PRACTICE; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEUS INFECTION; PROTEUS MIRABILIS; PROTEUS MIRABILIS INFECTION; RESIDUAL URINE; URINARY CATHETER; ADVERSE EFFECTS; BIOLOGICAL MODEL; DRAINAGE; GROWTH, DEVELOPMENT AND AGING; HUMAN; INDWELLING CATHETER; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PHAGE THERAPY; PROCEDURES; PROTEUS INFECTIONS; TRANSMISSION ELECTRON MICROSCOPY; VIROLOGY;

BACTERIOPHAGES; BIOFILMS; CATHETERS, INDWELLING; DRAINAGE; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, BIOLOGICAL; PHAGE THERAPY; PROTEUS INFECTIONS; PROTEUS MIRABILIS; URINARY CATHETERIZATION; URINARY CATHETERS;

EID: 84960192183     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02685-15     Document Type: Article

References (20)

1. Stickler DJ. 2008. Bacterial biofilms in patients with indwelling urinary catheters. Nat Rev Urol 5:598-608. http://dx.doi.org/10.1038/mcpuro1231.
2. Mobley HLT. 1996. Virulence of Proteus mirabilis, p 245-265. In Mobley HLT, Warren JW (ed), Urinary tract infections, molecular pathogenesis and clinical management. ASM Press, Washington, DC.
3. Griffith DP, Musher DM, Itin C. 1976. Urease: the primary cause of infection-induced urinary stones. Invest Urol 13:346-350.
4. Jones BD, Mobley HL. 1987. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection. Infect Immun 55:2198-2203.
5. Stickler D, Ganderton L, King J, Nettleton J, Winters C. 1993. Proteus mirabilis biofilms and the encrustation of urethral catheters. Urol Res 21:407-411. http://dx.doi.org/10.1007/BF00300077.
6. Clapham L, McLean RJC, Nickel JC, Downey J, Costerton JW. 1990. The influence of bacteria on struvite crystal habit and its importance in urinary stone formation. J Cryst Growth 104:475-484. http://dx.doi.org/10.1016/0022-0248 (90) 90150-J.
7. Dumanski AJ, Hedelin H, Edin-Liljegren A, Beauchemin D, McLean RJ. 1994. Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi. Infect Immun 62:2998-3003.
8. Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME. 2008. Complicated catheter-associated urinary tract infections due toEscherichia coli and Proteus mirabilis. Clin Microbiol Rev 21:26-59. http://dx.doi.org/10.1128/CMR.00019-07.
9. Morris NS, Stickler DJ, Winters C. 1997. Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br J Urol 80:58-63. http://dx.doi.org/10.1046/j.1464-410X.1997.00185.x.
10. Morgan S, Rigby D, Stickler DJ. 2009. A study of the structure of the crystalline biofilms that encrust and block silver Foley catheters. Urol Res 37:88-93. http://dx.doi.org/10.1007/s00240-009-0176-6.
11. Sabbuba NA, Mahenthiralingam E, Stickler DJ. 2003. Molecular epidemiology of Proteus mirabilis infections of the catheterized urinary tract. J Clin Microbiol 41:4961-4965. http://dx.doi.org/10.1128/JCM.41.11.4961-4965.2003.
12. Stickler DJ, Morris NS, Winters C. 1999. Simple physical model to study formation and physiology of biofilms on urethral catheters. Methods Enzymol 310:494-501. http://dx.doi.org/10.1016/S0076-6879 (99) 10037-5.
13. Holling N, Lednor D, Tsang S, Bissell A, Campbell L, Nzakizwanayo J, Dedi C, Hawthorne JA, Hanlon G, Ogilvie LA, Salvage JP, Patel BA, Barnes LM, Jones BV. 2014. Elucidating the genetic basis of crystalline biofilm formation in Proteus mirabilis. Infect Immun 82:1616-1626. http://dx.doi.org/10.1128/IAI.01652-13.
14. Carson L, Gorman SP, Gilmore BF. 2010. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol Med Microbiol 59:447-455. http://dx.doi.org/10.1111/j.1574-695X.2010.00696.x.
15. Curtin JJ, Donlan RM. 2006. Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 50:1268-1275. http://dx.doi.org/10.1128/AAC.50.4.1268-1275.2006.
16. Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM. 2010. Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54:397-404. http://dx.doi.org/10.1128/AAC.00669-09.
17. Lehman SM, Donlan RM. 2015. Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheterassociated urinary tract infections in an in vitro urinary catheter model. Antimicrob Agents Chemother 59:1127-1137. http://dx.doi.org/10.1128/AAC.03786-14.
18. Armbruster CE, Mobley HLT. 2012. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat Rev Microbiol 10:743-754. http://dx.doi.org/10.1038/nrmicro2890.
19. Sutherland IW, Hughes KA, Skillman LC, Tait K. 2004. The interaction of phage and biofilms. FEMS Microbiol Lett 232:1-6. http://dx.doi.org/10.1016/S0378-1097 (04) 00041-2.
20. Lu TK, Collins JJ. 2007. Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci U S A 104:11197-11202. http://dx.doi.org/10.1073/pnas.0704624104.